Diabetes Mellitus, Type 2
"Diabetes Mellitus, Type 2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
| Descriptor ID |
D003924
|
| MeSH Number(s) |
C18.452.394.750.149 C19.246.300
|
| Concept/Terms |
Diabetes Mellitus, Type 2- Diabetes Mellitus, Type 2
- Diabetes Mellitus, Noninsulin-Dependent
- Diabetes Mellitus, Ketosis-Resistant
- Diabetes Mellitus, Ketosis Resistant
- Ketosis-Resistant Diabetes Mellitus
- Diabetes Mellitus, Non Insulin Dependent
- Diabetes Mellitus, Non-Insulin-Dependent
- Non-Insulin-Dependent Diabetes Mellitus
- Diabetes Mellitus, Stable
- Stable Diabetes Mellitus
- Diabetes Mellitus, Type II
- NIDDM
- Diabetes Mellitus, Noninsulin Dependent
- Diabetes Mellitus, Maturity-Onset
- Diabetes Mellitus, Maturity Onset
- Maturity-Onset Diabetes Mellitus
- Maturity Onset Diabetes Mellitus
- MODY
- Diabetes Mellitus, Slow-Onset
- Diabetes Mellitus, Slow Onset
- Slow-Onset Diabetes Mellitus
- Type 2 Diabetes Mellitus
- Noninsulin-Dependent Diabetes Mellitus
- Noninsulin Dependent Diabetes Mellitus
- Maturity-Onset Diabetes
- Diabetes, Maturity-Onset
- Maturity Onset Diabetes
- Type 2 Diabetes
- Diabetes, Type 2
- Diabetes Mellitus, Adult-Onset
- Adult-Onset Diabetes Mellitus
- Diabetes Mellitus, Adult Onset
|
Below are MeSH descriptors whose meaning is more general than "Diabetes Mellitus, Type 2".
Below are MeSH descriptors whose meaning is more specific than "Diabetes Mellitus, Type 2".
This graph shows the total number of publications written about "Diabetes Mellitus, Type 2" by people in this website by year, and whether "Diabetes Mellitus, Type 2" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 1 | 2 |
| 1996 | 7 | 3 | 10 |
| 1997 | 1 | 0 | 1 |
| 1998 | 1 | 0 | 1 |
| 1999 | 4 | 2 | 6 |
| 2000 | 3 | 0 | 3 |
| 2001 | 2 | 1 | 3 |
| 2002 | 11 | 1 | 12 |
| 2003 | 9 | 4 | 13 |
| 2004 | 16 | 5 | 21 |
| 2005 | 10 | 7 | 17 |
| 2006 | 16 | 4 | 20 |
| 2007 | 14 | 5 | 19 |
| 2008 | 9 | 3 | 12 |
| 2009 | 19 | 3 | 22 |
| 2010 | 24 | 5 | 29 |
| 2011 | 27 | 6 | 33 |
| 2012 | 45 | 6 | 51 |
| 2013 | 31 | 8 | 39 |
| 2014 | 35 | 10 | 45 |
| 2015 | 42 | 6 | 48 |
| 2016 | 29 | 11 | 40 |
| 2017 | 34 | 14 | 48 |
| 2018 | 30 | 7 | 37 |
| 2019 | 32 | 10 | 42 |
| 2020 | 56 | 5 | 61 |
| 2021 | 54 | 10 | 64 |
| 2022 | 62 | 2 | 64 |
| 2023 | 56 | 3 | 59 |
| 2024 | 46 | 11 | 57 |
| 2025 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Diabetes Mellitus, Type 2" by people in Profiles.
-
Compounded GLP-1 and Dual GIP/GLP-1 Receptor Agonists: A Statement from the American Diabetes Association. Diabetes Care. 2025 Feb 01; 48(2):177-181.
-
Glucagon-like Peptide-1 Receptor Agonists in the Management of Diabetic Retinopathy. Int Ophthalmol Clin. 2025 Jan 01; 65(1):23-26.
-
The efficacy of using continuous glucose monitoring as a behaviour change tool in populations with and without diabetes: a systematic review and meta-analysis of randomised controlled trials. Int J Behav Nutr Phys Act. 2024 Dec 23; 21(1):145.
-
The role of the triglyceride-glucose index as a biomarker of cardio-metabolic syndromes. Lipids Health Dis. 2024 Dec 23; 23(1):416.
-
Insulin clearance at randomisation and in response to treatment in youth with type 2 diabetes: a secondary analysis of the TODAY randomised clinical trial. Diabetologia. 2025 Mar; 68(3):676-687.
-
Rising mortality rates linked to type-2 diabetes and obesity in the United States: An observational analysis from 1999 to 2022. J Diabetes Investig. 2025 Mar; 16(3):492-500.
-
Health implications of racial differences in serum growth differentiation factor levels among men with obesity. Physiol Rep. 2024 Dec; 12(23):e70124.
-
Pathophysiology and Treatment of Prediabetes and Type 2 Diabetes in Youth. Diabetes Care. 2024 Dec 01; 47(12):2038-2049.
-
Clinical Prediction Models Combining Routine Clinical Measures Have High Accuracy in Identifying Youth-Onset Type 2 Diabetes Defined by Maintained Endogenous Insulin Secretion: The SEARCH for Diabetes in Youth Study. Diabetes Care. 2024 Dec 01; 47(12):2110-2119.
-
Intensive Lifestyle Intervention, Cardiac?Biomarkers, and Cardiovascular?Outcomes in Diabetes: Look AHEAD Cardiac Biomarker Ancillary Study. J Am Coll Cardiol. 2025 Feb 11; 85(5):489-500.